A kinase-dead natural polymorphism in the canine Tnni3k gene
- PMID: 38828440
- PMCID: PMC11140478
- DOI: 10.17912/micropub.biology.001164
A kinase-dead natural polymorphism in the canine Tnni3k gene
Abstract
Most mammalian cardiomyocytes become polyploid in the neonatal period, concurrent with their loss of proliferative capacity. In mice, natural or engineered mutation of the cardiomyocyte-specific kinase gene Tnni3k causes a higher level of diploid CMs and a higher capacity to support proliferation after adult injury. Here, we identified a polymorphism in the canine Tnni3k gene that is particularly common in the West Highland White Terrier breed, and show that this variant eliminates Tnni3k kinase activity. Thus, in several species, natural Tnni3k polymorphisms exist that are predicted to contribute to variation in diploid CM level and heart regenerative ability.
Copyright: © 2024 by the authors.
Conflict of interest statement
The authors declare that there are no conflicts of interest present.
Figures

Similar articles
-
Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency.PLoS Genet. 2019 Oct 7;15(10):e1008354. doi: 10.1371/journal.pgen.1008354. eCollection 2019 Oct. PLoS Genet. 2019. PMID: 31589606 Free PMC article.
-
The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.Hum Mol Genet. 2021 Jan 6;29(21):3504-3515. doi: 10.1093/hmg/ddaa234. Hum Mol Genet. 2021. PMID: 33084860 Free PMC article.
-
MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.Cell Physiol Biochem. 2015;35(4):1546-56. doi: 10.1159/000373970. Epub 2015 Mar 12. Cell Physiol Biochem. 2015. PMID: 25792377
-
Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease.Circ J. 2014;78(7):1514-9. doi: 10.1253/circj.cj-14-0543. Epub 2014 Jun 5. Circ J. 2014. PMID: 24899531 Free PMC article. Review.
-
TNNI3K could be a novel molecular target for the treatment of cardiac diseases.Recent Pat Cardiovasc Drug Discov. 2009 Nov;4(3):203-10. doi: 10.2174/157489009789152285. Recent Pat Cardiovasc Drug Discov. 2009. PMID: 19925440 Review.
References
-
- Gan P, Baicu C, Watanabe H, Wang K, Tao G, Judge DP, Zile MR, Makita T, Mukherjee R, Sucov HM. The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice. Hum Mol Genet. 2021 Jan 6;29(21):3504–3515. doi: 10.1093/hmg/ddaa234. - DOI - PMC - PubMed
-
- Patterson M, Barske L, Van Handel B, Rau CD, Gan P, Sharma A, Parikh S, Denholtz M, Huang Y, Yamaguchi Y, Shen H, Allayee H, Crump JG, Force TI, Lien CL, Makita T, Lusis AJ, Kumar SR, Sucov HM. Frequency of mononuclear diploid cardiomyocytes underlies natural variation in heart regeneration. Nat Genet. 2017 Aug 7;49(9):1346–1353. doi: 10.1038/ng.3929. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources